Wiadomości giełdowe
Najnowsze wiadomości finansowe · Zaktualizowano Lip 24, 2026
Gigant handlowy w centrach handlowych zamyka ostatni sklep w kluczowym mieście po 26 latach
Mall retail giant closes final store in key city after 26 years
Despite positive trends like 7% Gap brand growth and 39% digital penetration, the panel is concerned about Athleta's 10% decline …
AMD Osiągnęło Rekordowy Poziom – Czy Jest Już Za Późno na Zakup?
AMD Just Hit an All-Time High -- Is it Too Late to Buy?
The panel discusses AMD's record-breaking quarter, with concerns around valuation, supply chain constraints, and demand visibility. The key debate revolves …
Acuta Capital postawił na Erasca (ERAS) i celowane terapie przeciwnowotworowe, kupując 354 575 akcji
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Despite Acuta Capital's significant investment, the panel is largely bearish due to ERAS-0015 trial's patient death, high cash burn rate, …
Czy Kailera Therapeutics to Dobry Zakup po Jej Gorącym IPO?
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Kailera Therapeutics' IPO is considered high-risk due to intense competition, lack of approved products, and substantial clinical and regulatory risks. …
Czy akcje LegalZoom są dobrym zakupem po tym, jak CEO kupił 125 000 akcji?
Is LegalZoom Stock a Buy After the CEO Purchased 125,000 Shares?
Despite a CEO buy signal, the panel is largely bearish due to LegalZoom's eroding moat from AI disruption, anemic margins, …
Greg Abel Kupuje Akcje Prawdopodobnie Ulubionej Akcji Warrena Buffetta. Czy Powinieneś Ją Kupić Również?
Greg Abel Is Buying Shares of What Is Probably Warren Buffett's Favorite Stock. Should You Buy It Too?
Panelists generally agree that Berkshire Hathaway's current cash hoard and buyback activity signal a defensive posture rather than a growth …
Pacjent Square Zawiera Duży Zakład na Nektar Pharmaceuticals (NKTR) Kupując 210 000 Akcji
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
Panelists generally agree that Patient Square's investment in NKTR signals confidence in Rezolve-AD's Phase 2b results, but they caution about …
Warren Buffett Mówił To Od Lat. 1 ETF Vanguard Wprowadza Tę Radę w Życie.
Warren Buffett Has Been Saying This for Years. 1 Vanguard ETF Puts That Advice Into Practice.
The panel agrees that VOO's high tech concentration (33%) poses significant risk, with potential for amplified volatility during corrections. They …
Ipsen: Dane dotyczące korabotazy wykazują szybką, trwałą skuteczność w przypadku linii gniewu
Ipsen : Corabotase Data Demonstrate Rapid, Durable Efficacy In Glabellar Lines
Ipsen's corabotase shows promising Phase II data with rapid onset and strong 24-week durability versus Dysport, but Phase III results …
Czy akcje WaterBridge są warte zakupu po tym, jak Ranger Investment zwiększył swój udział o 345 000 akcji?
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?
Despite Gemini's 'regulatory moat' argument, the panel consensus is bearish due to WaterBridge's high debt, lack of consistent profitability, and …
Lime Złożył Wniosek o IPO – Zamiast Tego Kup Ten Akcji
Lime Filed for an IPO -- Buy This Stock Instead
The panel consensus is bearish on Lime's IPO, citing the 'going concern' warning, Lime's debt maturity, and the risk of …
NVent Electric Zarząd Zatwierdza Program Odkupu Akcji o Wartości 500 mln USD
NVent Electric Board Approves $500 Mln Share Repurchase Program
The panel is neutral on NVT's $500M, 3-year buyback program. While the program is shareholder-friendly, the delayed start and lack …